Target intelligence / Profile preview

Serine protease HtrA (HtrA)

Target
HtrA
Molecular classification
Enzyme, Serine protease, Chaperone
01

Overview

Serine protease HtrA (High temperature requirement A) is a critical virulence factor and essential protein produced by the bacterium Helicobacter pylori (UniProt O25663). It functions as both a molecular chaperone in the periplasm, ensuring proper protein folding under stress, and as a secreted serine protease in the extracellular environment (NIH, PMID: 38231222). In the gastric mucosa, HtrA specifically targets and cleaves the extracellular domain of the host cell-adhesion protein E-cadherin, as well as other junctional proteins like claudin-8 and occludin (EMBO Rep, 2010). This proteolytic activity leads to the disruption of adherens and tight junctions, compromising the integrity of the gastric epithelial barrier and allowing H. pylori to invade the paracellular space (NIH, PMID: 27551158). Furthermore, HtrA-mediated cleavage of E-cadherin facilitates the translocation of other bacterial effectors, such as the oncoprotein CagA, into host cells (NIH, PMID: 21455477). Due to its dual role in bacterial physiology and host pathogenesis, HtrA is a high-priority target for the development of novel anti-infective agents aimed at treating H. pylori infections and preventing associated diseases like peptic ulcers and gastric cancer (NIH, PMID: 23433388). Experimental inhibitors like JO146 and various small molecules found through virtual screening have shown potential in blocking HtrA activity and bacterial invasion (PLoS ONE, 2011). However, achieving selectivity over human HtrA homologs remains a significant therapeutic challenge (NIH, PMID: 30144448).

Other names
High temperature requirement AHtrAHpHP1019DegPHelicobacter pylori extracellular protease
02

Mechanism of action

Inhibition of the serine protease activity of HtrA, preventing the cleavage of host E-cadherin and disrupting bacterial protein quality control, which leads to reduced bacterial survival and virulence.

03

Biological functions

ProteolysisProtein quality controlE-cadherin cleavageDisruption of cell junctionsStress responseMolecular chaperone activity
04

Disease associations

InfectionGastritisPeptic ulcerGastric cancerMALT lymphoma
05

Safety considerations

Potential off-target inhibition of human HtrA homologs (HTRA1, HTRA2, HTRA3, HTRA4)Disruption of normal host apoptotic and signaling pathwaysTherapeutic challenge of achieving bacterial specificity
06

Interacting drugs

JO146

4 more in the full profile.

07

Biomarkers

Soluble E-cadherin fragments (NTF)HtrA protein levels in gastric juiceHtrA expression in gastric biopsies

Beyond the preview

Go deeper on Serine protease HtrA (HtrA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Serine protease HtrA (HtrA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call